38 completed, 5 unknown, 3 terminated, 1 enrolling by invitation. 20 Phase 3, 8 Phase 1, 6 Phase 4, 5 Phase 2, 4 Not applicable.
Follow azilsartan: new trials by email Literature Review of azilsartan trials Research Report on azilsartan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
| Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention Losartan + Hydrochlorothiazide, Amlodipine + Azilsartan - Hypertension, Coronary Arterial Disease | Not applicable | Recruiting | National Medical Research Center for Therapy and Preventive Medicine | 207 | 2026-04-01 | 2026-07-06 |
| Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia) Azilsartan medoxomil 80 mg tablet, Edarbi® 80 mg tablets - Hypertension | Phase 1 | Not yet recruiting | Gedeon Richter Plc. | 56 | 2025-06-06 | 2025-05-25 |
| Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI - Hypertension, Atrial Fibrillation | Phase 4 | Unknown | Beijing Tsinghua Chang Gung Hospital | 400 | 2023-06-01 | 2023-05-03 |
| Azilsartan in Patients With Diabetic Kidney Disease and Hypertension Azilsartan, Losartan - Proteinuria, Kidney Dysfunction | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 106 | 2023-04-01 | 2023-03-03 |
| A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure Azilsartan (TAK-536) - Hypertension | Completed | Takeda | 5 | 2021-12-16 | 2025-09-10 | |
| A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers CTL0801 (Azilsartan), CTL0802 (Rosuvastatin), CTL0801 (Azilsartan) + CTL0802 (Rosuvastatin) - Health, Subjective | Phase 1 | Completed | Celltrion | 37 | 2021-07-23 | 2021-12-23 |
| A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure TAK-536 - Hypertension | Phase 3 | Completed | Takeda | 10 | 2021-05-17 | 2024-12-09 |
| Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty sacubitril/valsartan, Angiotensin II Receptor Blockers - Heart Failure, Systolic, Frailty | Unknown | Brigham and Women's Hospital | 40000 | 2021-01-14 | 2021-02-15 | |
| Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? Losartan, Valsartan, Azilsartan - Covid19, SARS-CoV Infection | Phase 3 | Terminated | University of British Columbia | 341 | 2020-10-09 | 2023-02-16 |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus. Azilsartan Medoxomil 40 MG Oral Tablet [Edarbi] - Arterial Hypertension, Diabetes Mellitus | Completed | Research Institute for Complex Problems of Cardiovascular Diseases, Russia | 184 | 2018-11-07 | 2022-10-26 | |
| A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation TAK-536 - Healthy Volunteers | Phase 1 | Completed | Takeda | 12 | 2018-02-14 | 2019-06-10 |
| Bioequivalence Study of Azilsartan Tablets in Chinese Healthy Volunteers Azilsartan (Zhaoke), Azilsartan (Takeda) - Bioequivalence of Two Azilsartan Formulations | Phase 1 | Completed | Lee's Pharmaceutical Limited | 60 | 2018-01-22 | 2018-08-29 |
| A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation TAK-536 - Japanese Healthy Adult Male Participants | Phase 1 | Completed | Takeda | 14 | 2017-02-10 | 2018-11-14 |
| Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers 20mg Azilsartan Tablets, 40mg Azilsartan Tablets - Hypertension | Phase 1 | Completed | Lee's Pharmaceutical Limited | 29 | 2016-11-01 | 2018-09-05 |
| A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension Azilsartan, Placebo - Pediatric Hypertension | Phase 3 | Completed | Takeda | 27 | 2016-08-18 | 2020-02-07 |
| International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan Azilsartan Medoxomil - Hypertension | Completed | Takeda | 1945 | 2016-07-18 | 2019-11-20 | |
| A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants TAK-491, TAK-491 placebo - Healthy Volunteer | Phase 1 | Completed | Takeda | 64 | 2015-11-20 | 2020-02-05 |
| Azilsartan in Chinese Patients With Mild and Moderate Hypertension Azilsartan tablets, Azilsartan placebo tablets, Olmesartan medoxomil tablets - Hypertension | Phase 3 | Completed | Lee's Pharmaceutical Limited | 304 | 2015-09-01 | 2018-09-04 |
Showing 20 of 50. Sign in to see all of them.
Hypertension (32) · Essential Hypertension (10) · Diabetes Mellitus, Type 2 (6) · Cardiovascular Diseases (5) · Diabetes Mellitus (2) · Dyslipidemias (2) · Obesity (2) · Vascular Diseases (2) · Acute Kidney Injury (1) · Albuminuria (1) · Angina, Stable (1) · Atrial Fibrillation (1) · COVID-19 (1) · Coronavirus Infections (1) · Diabetes Mellitus, Lipoatrophic (1)
Takeda (32) · Lee's Pharmaceutical Limited (3) · Baylor Research Institute (1) · Beijing Tsinghua Chang Gung Hospital (1) · Brigham and Women's Hospital (1) · Celltrion (1) · Gedeon Richter Plc. (1) · Hospital General de México Dr. Eduardo Liceaga (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Nara Medical University (1) · National Medical Research Center for Therapy and Preventive Medicine (1) · Research Institute for Complex Problems of Cardiovascular Diseases, Russia (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Sogo Rinsho Médéfi Co., Ltd. (1) · University of British Columbia (1)
United States (15) · Japan (14) · Mexico (9) · China (7) · Argentina (6) · Peru (5) · Russia (5) · Chile (4) · Bulgaria (2) · Estonia (2) · France (2) · Germany (2) · Netherlands (2) · Poland (2) · Puerto Rico (2)
Adam P Bress, PharmD, MS (1) · Antonio Peralta, MD (1) · Dae Hyun Kim, MD, MPH, ScD (1) · Estrella Martinez, RN (1) · George Bakris, MD (1) · He Rong, M.D., Ph.D (1) · James A Russell, MD (1) · Karen Tran, MD (1) · Kazuo Kario (1)
PMID 21282560, PMID 21272195, PMID 21762358, PMID 25619410, PMID 25646296, PMID 30027478, PMID 30175930, PMID 30943275, PMID 32769878, PMID 33891615, PMID 38682786, PMID 39325643